Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication

Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection

(2013) Terence N. Bukong et al.   HEPATOLOGY

Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication

(2013) Ian A. Rowe et al.   HEPATOLOGY

Osteopontin: Versatile modulator of liver diseases

(2013) Sumiko Nagoshi   HEPATOLOGY RESEARCH

Underlying potential: cellular and molecular determinants of adult liver repair

(2013) Anna Mae Diehl et al.   JOURNAL OF CLINICAL INVESTIGATION

How to optimize HCV therapy in genotype 1 patients: predictors of response

(2013) Salvatore Petta et al.   LIVER INTERNATIONAL

NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease

(2012) Wing-Kin Syn et al.   GUT

Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans

(2012) James Pritchett et al.   HEPATOLOGY

Single-nucleotide polymorphism in the promoter region of the osteopontin gene at nucleotide −443 as a marker predicting the efficacy of pegylated interferon/ribavirin-therapy in Egyptians patients with chronic hepatitis C

(2012) Olfat Gamil Shaker et al.   HUMAN IMMUNOLOGY

The Osteopontin Level in Liver, Adipose Tissue and Serum Is Correlated with Fibrosis in Patients with Alcoholic Liver Disease

(2012) Stéphanie Patouraux et al.   PLoS One

Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection

(2011) Sabrina Corbetta et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Identification of osteopontin as a novel marker for early hepatocellular carcinoma

(2011) Sufen Shang et al.   HEPATOLOGY

Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus

(2011) Jean-Michel Pawlotsky   HEPATOLOGY

Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication

(2011) Steve S. Choi et al.   HEPATOLOGY

Unknown

(2011) Michal Kukla et al.   MOLECULAR MEDICINE

Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cells

(2011) Lindsay Jones Talbot et al.   SURGERY

Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis

(2010) Wing-Kin Syn et al.   HEPATOLOGY

The role of Hedgehog signaling in fibrogenic liver repair

(2010) Steve S. Choi et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis and hepatocellular carcinoma

(2010) Thiago de Almeida Pereira et al.   LABORATORY INVESTIGATION

Categorical meta-analysis of Osteopontin as a clinical cancer marker

(2010) Weber   ONCOLOGY REPORTS

Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis

(2009) Steve S. Choi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Hedgehog-Mediated Epithelial-to-Mesenchymal Transition and Fibrogenic Repair in Nonalcoholic Fatty Liver Disease

(2009) Wing–Kin Syn et al.   GASTROENTEROLOGY

Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production

(2009) Alessia Omenetti et al.   HEPATOLOGY

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

RNA Aptamer Blockade of Osteopontin Inhibits Growth and Metastasis of MDA-MB231 Breast Cancer Cells

(2008) Zhiyong Mi et al.   MOLECULAR THERAPY